151 related articles for article (PubMed ID: 1124554)
21. [A clinical study of sixteen polycythemia vera cases--acute myeloblastic leukemia in patients with polycythemia vera].
Takeyama H; Shimokawa T; Yamada H; Watanabe E
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2833-7. PubMed ID: 7993124
[TBL] [Abstract][Full Text] [Related]
22. [Karyotype studies in primary polycythemia vera (author's transl)].
Berger R; Parmentier C; Droz JP
Nouv Rev Fr Hematol; 1974; 14(6):705-12. PubMed ID: 4282500
[No Abstract] [Full Text] [Related]
23. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Nand S; Stock W; Godwin J; Fisher SG
Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
[TBL] [Abstract][Full Text] [Related]
24. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
Marchioli R; Finazzi G; Landolfi R; Kutti J; Gisslinger H; Patrono C; Marilus R; Villegas A; Tognoni G; Barbui T
J Clin Oncol; 2005 Apr; 23(10):2224-32. PubMed ID: 15710945
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of polycythemia vera with 32phosphorus (author's transl)].
Zhou Q
Zhonghua Fang She Xue Za Zhi; 1979; 13(3):140-3. PubMed ID: 162387
[No Abstract] [Full Text] [Related]
26. [Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera].
Tesselaar ME; Wijermans PW; Metsaars JA; Gerrits WB; Haak HL
Ned Tijdschr Geneeskd; 1996 Sep; 140(38):1900-2. PubMed ID: 8927166
[TBL] [Abstract][Full Text] [Related]
27. [Polycythemia vera, clinical aspects and disease course].
Heilmann E; Köhler T
Fortschr Med; 1978 May; 96(18):941-6. PubMed ID: 648997
[TBL] [Abstract][Full Text] [Related]
28. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
Bai J; Xue YP; Ye L; Yao JF; Zhou CL; Qian LS; Yang RC; Li HY; Zhang HY; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):685-8. PubMed ID: 18399175
[TBL] [Abstract][Full Text] [Related]
29. Essential thrombocythemia following polycythemia vera: an unusual sequence.
Randi ML; Barbone E; Zerbinati P; Soini B; Rossi C; Girolami A
J Med; 1996; 27(5-6):363-8. PubMed ID: 9151204
[TBL] [Abstract][Full Text] [Related]
30. Resistance to therapy of acute leukemia developing in the course of polycythemia vera.
Donovan PB; Landaw SA; Dresch C; Gartenhaus WS; Goldberg JD; Ellis JT; Loeb V; Perry MC; Petitt RM; Pisciotta AV; Silver RT; Spurr CL; Weinfeld A; Berk PD
Nouv Rev Fr Hematol (1978); 1981; 23(4):187-92. PubMed ID: 7312612
[TBL] [Abstract][Full Text] [Related]
31. Course and transformation of polycythaemia vera in relation to therapy.
Burger T; Schmelczer M; Molnár L; Pajor L; Koszorus S
Acta Med Hung; 1988; 45(1):97-113. PubMed ID: 3412864
[TBL] [Abstract][Full Text] [Related]
32. Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.
Passamonti F; Malabarba L; Orlandi E; Baratè C; Canevari A; Brusamolino E; Bonfichi M; Arcaini L; Caberlon S; Pascutto C; Lazzarino M
Haematologica; 2003 Jan; 88(1):13-8. PubMed ID: 12551821
[TBL] [Abstract][Full Text] [Related]
33. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
Ellis JT; Peterson P; Geller SA; Rappaport H
Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
[TBL] [Abstract][Full Text] [Related]
34. Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
Boivin P
Nouv Rev Fr Hematol (1978); 1993; 35(5):491-8. PubMed ID: 8295823
[TBL] [Abstract][Full Text] [Related]
35. [Radioactive phosphorus (32P); an old, but not bad treatment in polycythemia vera].
Michiels JJ; van Genderen PJ
Ned Tijdschr Geneeskd; 1997 Jan; 141(3):168-9. PubMed ID: 9053768
[No Abstract] [Full Text] [Related]
36. Polycythemia vera: diagnosis and treatment 2002.
Berlin NI
Expert Rev Anticancer Ther; 2002 Jun; 2(3):330-6. PubMed ID: 12113056
[TBL] [Abstract][Full Text] [Related]
37. [Association of polycythemia vera and multiple myeloma. Presentation ofa new case and review of the literature].
Prósper F; Paloma MJ; Rifón J; Cuesta B; Hermida J; Rocha E
Sangre (Barc); 1993 Dec; 38(6):497-9. PubMed ID: 8171387
[TBL] [Abstract][Full Text] [Related]
38. [Night/day plasma iron metabolism studies in patients with polycythaemia vera (author's transl)].
Triana YG; Putintseva E; Hernández P; Callejas J; Alvarez ME
Sangre (Barc); 1981; 26(6):1091-6. PubMed ID: 7200640
[No Abstract] [Full Text] [Related]
39. Busulfan versus 32P in polycythaemia vera.
Zittoun R
Drugs Exp Clin Res; 1986; 12(1-3):283-5. PubMed ID: 3525077
[TBL] [Abstract][Full Text] [Related]
40. [Functional state of the adrenal cortex in the radiation and drug therapy of polycythemia vera].
Belugina ZT
Med Radiol (Mosk); 1979 May; 24(5):52-7. PubMed ID: 440042
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
